WEBINAR: Excellence In Anti-Idiotype Antibody Discovery

By Travis LeGuyader - October 28, 2019

Date: November 13, 2019 at 2PM ET (11AM PT)

TraceyMullenPlease join Abveris' Chief Operating Officer, Tracey Mullen, for our webinar to learn more about our premier anti-idiotype antibody discovery service for mAbs, bispecifics, scFvs, VHHs, and more.

Benefits of our approach:
  • Rapid reagent generation timelines
  • Maximal epitope coverage with DiversimAb technology
  • Highly sensitive specificity screening
  • Identification of high-affinity mAbs
  • Neutralizing and non-neutralizing mAbs
  • Flexible deliverable strategies
  • All work done in the USA

Abveris has the expertise and technology advantages required to develop high-quality reagents to the trickiest biotherapeutic molecules. Join our webinar to learn more.

Interested, but have a scheduling conflict? Click here to register and a video link will be sent after the webinar finishes. 


Click Here to register Nov. 13th at 2PM EST (11AM PST) .    Click Here to view our anti-idiotype package pricing

unnamed

ANTIBODY DISCOVERY

Therapeutic antibody discovery for tough targets.

High-quality science and differentiated discovery technologies coordinated by experienced industry scientists, all the way from antigen design to antibody lead. Royalty-free formats available.

LEARN MORE ABOUT OUR SCIENCE
Comments

We promise that we won't SPAM you.